Platelet-rich plasma (PRP).
Kamran Balighi 1 MD, Martin Kassir2 MD,Maryam Vahedi Namin1MD,Alireza Ghanadan3 , Nasim Tootoonchi 1 MD.
  1. Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of medical sciences, Tehran, Iran.
  2. Worldwide laser institute, Dallas, TX, USA
  3. Dermatopathology department, Razi Hospital, Tehran University of Medical Sciences,Tehran,Iran.
* Corresponding author: Nasim Tootoonchi, Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Razi Hospital- Vahdate Eslami Street- Tehran- Iran
Zip code: 1199663911 Tel: 00982155618989
Email address: doctor.tootoonchi@gmail.com
Acknowledgment: This research has been supported by Tehran University of medical sciences.
Conflicts of Interest : No relevant conflicts of interest to disclose.The study protocol was approved by the ethics committee of Tehran University of Medical Sciences .
Authors Contribution Statement
Kamran balighi: conception and design, revising the manuscript, Given final approval Martin Kassir: conception and design, revising the manuscript, Maryam Vahedi Namin: acquisition of data, drafting the manuscript. Alireza Ghanadan: acquisition of data. Nasim Tootoonchi: drafting the manuscript, analysis and interpretation of data.
Title: Progression of Pseudolymphoma to true Cutaneous lymphoma, possible role ofPlatelet-rich plasma (PRP), a case report.
Running Title: Progression to lymphoma after